2019 Texas Regional HIMSS Conference

Monday 10 AM Opening Keynote: Rebecca Kaul

Kaul
  

Rebecca Kaul is Vice President and Chief Innovation Officer at the world-renowned MD Anderson Cancer Center. Building on the institution’s rich history of innovation, Rebecca is bringing another layer of transformative thinking through an Innovation Center designed to identify creative and effective approaches for delivering exceptional patient outcomes and bring new solutions to market. By collaborating with internal innovators and establishing strategic relationship with startups and industry, Rebecca and her team are accelerating value generation and commercialization.

Prior to joining MD Anderson, Rebecca served as Chief Innovation Officer and President of the University of Pittsburgh Medical Center’s (UPMC) Technology Development Center where she built their Innovation Center from a conceptual idea to a center nationally recognized for developing an extensive portfolio of partnerships, investments and new companies.  Prior to starting the UPMC Innovation Center, Rebecca led their joint venture, which yielded a 100% return on investment in 18 months.

Rebecca has a Master of Business Administration from New York University and has earned multiple degrees from Carnegie Mellon University: Master of Information Systems Management, Bachelor of Science in Chemical Engineering and Engineering and Public Policy.


Tuesday 2 PM Closing Keynote Interviewer: Emma Cartmell

Cartmell

Emma Cartmell joined Cappello Group as Managing Director in 2017, following a 20-year career building, acquiring, selling and taking companies public.  Ms. Cartmell has served in multiple C-level positions for both public and private companies and has deep expertise in the healthcare technology and technology-enabled healthcare services industries.  Under her leadership and guidance, healthcare companies have created and bought to market successful products and services that have led to successful exits.

Prior to joining Cappello, Ms. Cartmell served as the COO of NantHealth, a $1B private equity fund where she built the team and led investments and acquisitions of more than 50 companies.  Before that, Ms. Cartmell was the COO of Personalized Medicine at Abraxis BioScience where she prepared the company for sale and helped negotiate an 8x revenue sale to Celgene for $2.9B.  Earlier in her career, she was VP of Healthcare Advanced Programs and Director of Business Development at SAIC where she held both P&L and revenue-generating responsibilities for a $500M healthcare business and assisted with SAIC’s IPO road show materials.

Ms. Cartmell has developed M&A strategies for public and private companies on both the buy and sell-side, with investment targets of up to $1B.  She also advises the Morgan Stanley Equity Research team on the Digital Health Market.  She personally invests in healthcare technology start-ups, both individually and as a member of the Central Texas Angel Network, and helps guide them towards successful exits through her extensive healthcare industry knowledge and relationships.

Ms. Cartmell serves on the boards of the following companies and industry associations: HIMSS North America (non-profit), Austin Healthcare Council (non-profit), Morgan Stanley’s Equity Expansion Fund and multiple start-ups, including B.Well, Care.Coach and Accordion Health (acquired in 2017).  In 2013, Ms. Cartmell was appointed as an advisor to both the U.S. and British governments on healthcare technology trade and investment, and she presents regularly at Health DataPalooza on the international venture capital markets.

Ms. Cartmell was recently awarded the John. A Page Outstanding Service Award at HIMSS17 for her leadership in HIMSS and the Healthcare Industry.  Ms. Cartmell holds a Masters of Science degree from King’s College London.


Tuesday 2 PM Closing Keynote: Karen DeSalvo

DeSalvo

Karen DeSalvo, MD, MPH, MSc is a physician dedicated to improving the health of all people, with a particular focus on vulnerable populations, through patient care, education, policy and administrative roles, research, and public service.  Her commitment to improving the public’s health includes work beyond ensuring access to quality, affordable medical care, to strengthening the public health infrastructure, and enabling public-private partnerships that can address the social determinants of health.  She is currently Professor of Medicine and Population Health at the University of Texas at Austin Dell Medical School. 

Dr. DeSalvo served as Acting Assistant Secretary for Health at the U.S. Department of Health and Human Services (HHS) in the Obama Administration. In that role, she oversaw 12 core public health offices and 10 regional health offices across the nation, and the Office of the Surgeon General. Under Dr. DeSalvo’s leadership as Delivery System Reform strategy co-lead, HHS set and met historic goals in payment reform, supported transformed models of care delivery including in primary care, and changed the approach to information distribution in the health system.  

She also served as the National Coordinator for Health Information Technology from 2014 to 2016, a role in which she was responsible for setting national strategy and policy on health IT and focused interoperability in the health setting.  She marshaled public and private stakeholders to create and execute on a revised national strategy for health IT that shifts focus from electronic health records to standardized data, freed through requiring published APIs (application programmable interfaces) and supports a culture and business environment for information flow to support better health for individuals and communities. 

Following Hurricane Katrina, she was a community leader in building an innovative and award-winning model of neighborhood-based community health services for low-income, uninsured and other vulnerable people in the New Orleans area.  Just prior to joining HHS, Dr. DeSalvo served as New Orleans Health Commissioner where she transformed the Health Department in to one that is nationally accredited and recognized for addressing the broad determinants of health.  As Health Commissioner, Dr. DeSalvo led a transformational and successful effort to address major health challenges in her community including violence, nutritional and physical fitness and mental health.  She also led the re-establishment of a community public hospital.  

Dr. DeSalvo was previously professor of medicine and vice dean for community affairs and health policy at the Tulane School of Medicine.  She is a member of the National Academy of Medicine and the Medicare Payment Advisory Commission.  She also serves on the Board of Directors for Humana.  Dr. DeSalvo earned her Medical Doctorate and Master’s in Public Health from Tulane University, and Master's in Clinical Epidemiology from Harvard School of Public Health.   


Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!
MSN MSN
Top